Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » MIOTEPA 100 - Thiotepa for Injection USP 100 mg
miotepa 100
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info

MIOTEPA 100 - Thiotepa for Injection USP 100 mg

MBA Pharmaceuticals Pvt Ltd
Category: 
Pharma & Supplements
Drugs

MIOTEPA 100

Medicine composition: Thiotepa for Injection USP 100 mg

Dosage Form: Injection

Packing: 1*Vial

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Similar to Tepadine

Description:

Thiotepa is indicated to reduce the risk of graft rejection when used in conjunction with high-dose Busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (Hscn for pediatric patients with class3 beta-thalassemia.

Thiotepa is indicated for the treatment of adenocarcinoma of the breast or ovary.

Thiotepa is indicated for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities.

Thiotepa is indicated for the treatment of superficial papillary carcinoma of the urinary bladder.

View this product at mbapharmaceuticals.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree